GENOMIC VISION
Genomic Vision is a biotechnology company that combines pioneering Molecular Combing, a proprietary single DNA molecule detection technology, with biomarker discovery to develop and commercialize novel genetic tests and research tools for life sciences. Genomic Vision’s products focus on DNA analysis and genetic testing in the fields of cancer, rare inherited disorders and pharmacogenomics.
GENOMIC VISION
Industry:
Biotechnology Genetics
Founded:
2005-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.genomicvision.com
Total Employee:
51+
Status:
Active
Contact:
33(0)155-422-929
Total Funding:
8.68 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network
Similar Organizations
AdnaGen
AdnaGen AG is a biotechnology company that develops molecular genetic diagnostic testing systems for the medical and clinical research
Current Employees Featured
Founder
Stock Details
Investors List
Societe Generale Asset Management
Societe Generale Asset Management investment in Series B - Genomic Vision
Vesalius Biocapital Partners
Vesalius Biocapital Partners investment in Series B - Genomic Vision
Societe Generale Asset Management
Societe Generale Asset Management investment in Series A - Genomic Vision
Official Site Inspections
http://www.genomicvision.com Semrush global rank: 7.05 M Semrush visits lastest month: 619
- Host name: 208.91.197.132
- IP address: 208.91.197.132
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
More informations about "Genomic Vision"
Genomic Vision - Crunchbase Company Profile
Genomic Vision is a biotechnology company that combines pioneering Molecular Combing, a proprietary single DNA molecule detection technology, with biomarker discovery to develop and commercialize novel genetic tests and …See details»
Genomic Vision: Contact Details and Business Profile
Https://www.genomicvision.com Ticker: GV Revenue: $7 million: Funding: $23 million: Employees: 61 (61 on RocketReach) Founded: 2005: Address: 80-84 Rue Des Meuniers, Bagneux, Ile-de …See details»
Genomic Vision - Company Profile - Tracxn
Dec 30, 2024 Genomic Vision - Nanotechnology for single DNA analysis for cancer and acute disease molecular diagnostics. Public Company. Raised a total funding of $8.7M over 3 …See details»
Genomic Vision - LinkedIn
Genomic Vision Biotechnology Research Bagneux, Paris Area 4,116 followers Genomic Vision is a French biotech providing tools and services to visualize and characterize single DNA …See details»
Company Genomic Vision - MarketScreener.com
Jul 10, 2022 Genomic Vision specializes in developing genetic diseases diagnosis tests and cancer genomic analysis. The group uses molecular combing technology which allows direct …See details»
Genomic Vision Company Overview, Contact Details
Genomic Vision partnered with The Institute of Cancer Research on Apr 28th '23. Genomic Vision (FR0011799907 - GV, - the "Company"), a Euronext-listed biotechnology company that …See details»
Genomic Vision - Craft
Feb 7, 2024 Genomic Vision has 5 employees at their 1 location and €1.03 m in annual revenue in FY 2022. See insights on Genomic Vision including office locations, competitors, revenue, …See details»
Genomic Vision Overview | SignalHire Company Profile
Genomic Vision is a public company that has been in the industry for 20 years. The company currently specializes in the Biotechnology area. The position of the Co-Founder & CEO is …See details»
Genomic Vision Société Anonyme - Overview, News & Similar
Oct 23, 2023 Genomic Vision Société Anonyme contact info: Phone number: +33 149080740 Website: www.genomicvision.com What does Genomic Vision Société Anonyme do? Genomic …See details»
Genomic Vision Initial Public offering on Euronext
Dec 15, 2023 Listing Genomic Vision on Euronext Paris. ISIN : FR0011799907. Genomic Vision est spécialisé dans le développement de tests de diagnostic des maladies génétiques et …See details»
Genomic Vision Company Profile 2024: Stock Performance
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; FR-3121369-A1: Automatic device for successively grinding, collecting and simultaneously transferting a …See details»
Genomic Vision Management Team | Org Chart - RocketReach
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases.See details»
Genomic Vision - Company Profile & Staff Directory - ContactOut
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases. These …See details»
Genomic Vision announces successful beta testing of
May 1, 2023 Genomic Vision Aaron Bensimon CEO Phone: +33 1 49 08 07 51 Email: [email protected]: Consilium Strategic Communications International Investor …See details»
Genomic Vision - selectscience.net
GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases.See details»
GENOMIC VISION | VentureRadar
Website: http://www.genomicvision.com. Genomic Vision has developed a pioneering approach for genomic analyses called molecular combing technology, which allows the ...See details»
Genomic Vision | Science Company - Labroots
Oct 19, 2021 GENOMIC VISION develops novel diagnostic and drug discovery solutions based on its world-leading nanotechnology for DNA analysis in the areas of cancer and acute diseases.See details»
Genomic Vision - Products, Competitors, Financials, Employees ...
Aug 4, 2014 However, there can be no assurance that such forward-looking statements will be verified, which statements are subject to numerous risks, including the risks set forth in the …See details»
Genomic Vision’s cutting-edge TeloSizer® application to be
Nov 29, 2022 Genomic Vision Aaron Bensimon CEO Phone: +33 1 49 08 07 51 Email: [email protected]: Consilium Strategic Communications International Investor …See details»
Genomic Vision : Le pari réussi d’un chercheur devenu entrepreneur
Jan 31, 2012 Chercheur et découvreur, Aaron Bensimon a ajouté une corde à son arc, celle de l’entrepreneuriat. Ce docteur en biologie moléculaire, diplômé du Weismann Institute of …See details»